-
AIIMS Delhi starts screening of children for Covaxin trials
The trial on children has already started at AIIMS Patna to see if the Bharat Biotech jab is suitable for children.
-
Brazil clears import of Bharat Biotech’s Covaxin, Russia’s Sputnik V
According to Brazillian health regulator Anvisa, Brazil is expected to receive four million doses of Covaxin initially.
-
Will be able to manufacture, supply 10 crore Covishield doses in June: Serum Institute to Centre
In early May, SII had communicated to the Centre that production of Covishield would be ramped up to 6.5 crore in June, seven crore in July and 10 cro
-
Covaxin manufacturing to vaccination takes 4 months, says Bharat Biotech
The timeline for manufacturing, testing and release for a batch of Covaxin is approximately 120 days, depending on the technology framework and regula
-
Covid-19 vaccine: ICMR to examine effectiveness of Covishield and Covaxin
The cumulative vaccine doses administered in the country has crossed 20 crore so far
-
Covishield stock for 45+ age group left for 12 days: Atishi
On May 25, of the 43,824 doses administered, over 33,000 were given to those getting their first shots and about 10,000 for those receiving their seco
-
Bharat Biotech expects EUA from WHO for Covaxin in July- September
Bharat Biotech said regulatory approvals for Covaxin are in process in more than 60 countries including the USA, Brazil and Hungary among others
-
Covid-19 positivity rate down to 9.54%: Union health ministry
India's daily recoveries continue to outnumber the daily new cases for the 12th consecutive day
-
Bharat Biotech’s US partner Ocugen submits ‘Master File’ to FDA on Covaxin
Ocugen is expecting the vaccine to be rolled out in the US during the second half of the year 2021.
-
Covid-19: India records over 2.4 lakh fresh cases, 3,741 fatalities
The Covid-19 active cases have reduced to 28,05,399 comprising 10.57 % of the total infections
